# OrbiMed's Pharma Investments: 26 Startups in Its Portfolio (2026) > The 26 Pharma startups OrbiMed has backed, by stage: $3.7B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/orbimed-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 12 - [Mineralys Therapeutics](https://millionrounds.com/company/mineralys-therapeutics) - [Cullinan Therapeutics](https://millionrounds.com/company/cullinan-therapeutics) - [Harmony Biosciences](https://millionrounds.com/company/harmony-biosciences) - [Verastem Oncology](https://millionrounds.com/company/verastem-oncology) - [Whitehawk Therapeutics](https://millionrounds.com/company/whitehawk-therapeutics) - [Shattuck Labs](https://millionrounds.com/company/shattuck-labs) - [*N* NeurAxon](https://millionrounds.com/company/neuraxon) - [EUSA Pharma](https://millionrounds.com/company/eusa-pharma) - [Xilio Therapeutics](https://millionrounds.com/company/xilio-therapeutics) - [ImageneBio](https://millionrounds.com/company/imagenebio) - [ReCode Therapeutics](https://millionrounds.com/company/recode-therapeutics) - [Lomond Therapeutics](https://millionrounds.com/company/lomond-therapeutics) ## Series B 7 - [Corvus Pharmaceuticals](https://millionrounds.com/company/corvus-pharmaceuticals) - [Adicet Bio](https://millionrounds.com/company/adicet-bio) - [Curevo](https://millionrounds.com/company/curevo) - [Pathalys Pharma](https://millionrounds.com/company/pathalys-pharma) - [Clementia Pharmaceuticals](https://millionrounds.com/company/clementia-pharmaceuticals) - [Pinnacle Medicines](https://millionrounds.com/company/pinnacle-medicines) - [Rempex Pharmaceuticals](https://millionrounds.com/company/rempex-pharmaceuticals) ## Series C and later 5 - [ACELYRIN](https://millionrounds.com/company/acelyrin) - [ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals) - [Aduro BioTech](https://millionrounds.com/company/aduro-biotech) - [Targanta Therapeutics](https://millionrounds.com/company/targanta-therapeutics) - [Auxilium Pharmaceuticals](https://millionrounds.com/company/auxilium-pharmaceuticals) ## Series A 2 - [Rampart Bioscience](https://millionrounds.com/company/rampart-bioscience) - [Helicore Biopharma](https://millionrounds.com/company/helicore-biopharma) ## Segment by segment ### Stage not reported 12 startups · $1.8B raised - [**Mineralys Therapeutics**](https://millionrounds.com/company/mineralys-therapeutics) Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension. United States $788M - [**Cullinan Therapeutics**](https://millionrounds.com/company/cullinan-therapeutics) Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly. United States $280M - [**Harmony Biosciences**](https://millionrounds.com/company/harmony-biosciences) Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders. United States $248M - [**Verastem Oncology**](https://millionrounds.com/company/verastem-oncology) Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers. United States $90M - [**Whitehawk Therapeutics**](https://millionrounds.com/company/whitehawk-therapeutics) Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology. United States $88M - [**Shattuck Labs**](https://millionrounds.com/company/shattuck-labs) Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease. United States $75M - [*N* **NeurAxon**](https://millionrounds.com/company/neuraxon) NeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase. Canada $57M - [**EUSA Pharma**](https://millionrounds.com/company/eusa-pharma) EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products. United Kingdom $54M ### Series B 7 startups · $949M raised - [**Corvus Pharmaceuticals**](https://millionrounds.com/company/corvus-pharmaceuticals) Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company. United States $310M - [**Adicet Bio**](https://millionrounds.com/company/adicet-bio) Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for ca United States $175M - [**Curevo**](https://millionrounds.com/company/curevo) Curevo is a clinical-stage biotech firm that focuses on producing vaccines. United States $110M - [**Pathalys Pharma**](https://millionrounds.com/company/pathalys-pharma) Pathalys Pharma is a private biopharmaceutical company based in Raleigh, North Carolina, founded in 2021. United States $105M - [**Clementia Pharmaceuticals**](https://millionrounds.com/company/clementia-pharmaceuticals) Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. Canada $93M - [**Pinnacle Medicines**](https://millionrounds.com/company/pinnacle-medicines) Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs. United States $90M - [**Rempex Pharmaceuticals**](https://millionrounds.com/company/rempex-pharmaceuticals) Rempex Pharmaceuticals engages in the discovery and development of antibacterial drugs for antibiotic resistance. United States $68M ### Series C and later 5 startups · $804M raised - [**ACELYRIN**](https://millionrounds.com/company/acelyrin) ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies. United States $300M - [**ORIC Pharmaceuticals**](https://millionrounds.com/company/oric-pharmaceuticals) ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance. United States $248M - [**Aduro BioTech**](https://millionrounds.com/company/aduro-biotech) Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies. United States $143M - [**Targanta Therapeutics**](https://millionrounds.com/company/targanta-therapeutics) Targanta Therapeutics is a biopharma Company United States $70M - [**Auxilium Pharmaceuticals**](https://millionrounds.com/company/auxilium-pharmaceuticals) Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology an United States $43M ### Series A 2 startups · $150M raised - [**Rampart Bioscience**](https://millionrounds.com/company/rampart-bioscience) Rampart Bioscience is a private biotechnology company focused on developing non-viral, DNA-based gene medicines for genetically dr United States $85M - [**Helicore Biopharma**](https://millionrounds.com/company/helicore-biopharma) Helicore Biopharma is a private biopharmaceutical company based in San Mateo, California, focused on developing innovative weight- United States $65M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names OrbiMed as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **OrbiMed's Healthtech portfolio** 12 startups · $1.4B](https://millionrounds.com/portfolio-maps/orbimed-healthtech-portfolio)[Portfolio map **OrbiMed portfolio map** 221 startups · $34B](https://millionrounds.com/portfolio-maps/orbimed-portfolio-map)[Co-investors **Who invests with OrbiMed** 159 co-investors](https://millionrounds.com/portfolio-maps/orbimed-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio) ## Raising from investors like OrbiMed? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)